Anesthesia Drugs Market to Grow to $4.3 Billion by 2011 as Populations and Uses for Anesthesia Increase

Saturday, October 13, 2007 General News J E 4
NEW YORK, Oct. 12 New products, a growing world populationexpected to reach 6.8 billion in three years, as well as the aging of thatpopulation, will push anesthesia drug sales 1.9% to nearly $4.3 billion by2011, according to Anesthesia Drugs: Worldwide Markets, a new report byKalorama Information.

More than 300 million surgical procedures required anestheticadministration worldwide in 2006, and Kalorama Information expects that numberwill rise accordingly as the incidence and prevalence of disease grows withthe world population.

Adjunctive therapies, drugs given in the perioperative period tofacilitate and/or augment the anesthetic process, will likely represent thelargest percentage of growth during the forecast period primarily due to newdevelopments in the anesthesia reversal market. The adjunctive therapiesmarket grew from $793.3 million in 2004 to $825.5 million in 2006 and isexpected to reach $1.2 billion by 2011, an increase of 8.2%.

Trends affecting future growth of anesthesia drugs include research anddevelopment in several promising areas, including the treatment of depressionand sleep disorders and the growing use of conscious sedation, a procedurethat involves sedative drugs that lower the level of consciousness but doesn'tput a patient completely under.

"The availability of sedating drugs, such as fentanyl and Versed, has beena real boon to the industry," said Melissa Elder, author of Anesthesia Drugs."Advancements in the area of conscious sedation have resulted in nearly 70% ofsurgical procedures being performed in hospital outpatient departments,surgical centers, and doctor's offices, which allow doctors to performoperations ranging from tummy tucks to cardiac catheterizations without theneed for general anesthesia or an overnight hospital stay."

Anesthesia Drugs covers both currently marketed and late stage developmentanesthesia drugs worldwide with special emphasis on general, local, andadjunctive therapies in anesthesia in the U.S. The report analyzes productsin development and on the market, leading competitors, and current issues andtrends affecting the industry. This report can be purchased directly fromKalorama Information by visiting It isalso available at

About Kalorama Information

Kalorama Information, a division of, supplies thelatest in independent market research on medical markets. For moreinformation, contact Tom Ehart at 240-747-3014 or,or visit

SOURCE Kalorama Information


You May Also Like

View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
AMIA Announces Partnership with CDC to Enhance Pub...
SAE International Recognized for Workplace Wellnes...